| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Onintza Sagredo, Javier Palazuelos, Ana Gutierrez-Rodriguez, Valentina Satta, Ismael Galve-Roperh, José Martínez-Orgad. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders. Biochemical pharmacology. vol 157. 2019-07-08. PMID:30118663. |
in a second part, we discuss the available evidences of therapeutic actions of cannabidiol in children with refractory epilepsy syndromes. |
2019-07-08 |
2023-08-13 |
Not clear |
| Paula Province Warren, E Martina Bebin, L Burt Nabors, Jerzy P Szaflarsk. The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy. Neurocase. vol 23. issue 5-6. 2019-06-25. PMID:29063814. |
the use of cannabidiol for seizure management in patients with brain tumor-related epilepsy. |
2019-06-25 |
2023-08-13 |
Not clear |
| Paula Province Warren, E Martina Bebin, L Burt Nabors, Jerzy P Szaflarsk. The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy. Neurocase. vol 23. issue 5-6. 2019-06-25. PMID:29063814. |
our aim was to examine the safety and efficacy of pharmaceutical grade cannabidiol (cbd; epidiolex; greenwich biosciences) in those patients with epilepsy with concomitant tumors enrolled in the university of alabama at birmingham cbd program (nct02700412 and nct02695537). |
2019-06-25 |
2023-08-13 |
Not clear |
| Delphine Vincent, Simone Rochfort, German Spangenber. Optimisation of Protein Extraction from Medicinal Cannabis Mature Buds for Bottom-Up Proteomics. Molecules (Basel, Switzerland). vol 24. issue 4. 2019-06-03. PMID:30781766. |
medicinal cannabis is used to relieve the symptoms of certain medical conditions, such as epilepsy. |
2019-06-03 |
2023-08-13 |
Not clear |
| Jeremy L Freema. Safety of cannabidiol prescribed for children with refractory epilepsy. The Medical journal of Australia. vol 209. issue 5. 2019-05-30. PMID:30092751. |
safety of cannabidiol prescribed for children with refractory epilepsy. |
2019-05-30 |
2023-08-13 |
Not clear |
| Kerrie-Anne Chen, Michelle Farrar, Michael Cardamone, Deepak Gill, Robert Smith, Christopher T Cowell, Linda Truong, John A Lawso. Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience. The Medical journal of Australia. vol 209. issue 5. 2019-05-30. PMID:30092753. |
cannabidiol for treating drug-resistant epilepsy in children: the new south wales experience. |
2019-05-30 |
2023-08-13 |
Not clear |
| Kerrie-Anne Chen, Michelle Farrar, Michael Cardamone, Deepak Gill, Robert Smith, Christopher T Cowell, Linda Truong, John A Lawso. Cannabidiol for treating drug-resistant epilepsy in children: the New South Wales experience. The Medical journal of Australia. vol 209. issue 5. 2019-05-30. PMID:30092753. |
to evaluate the tolerability and safety of cannabidiol for treating drug-resistant epilepsy in children, and to describe adverse events associated with such treatment. |
2019-05-30 |
2023-08-13 |
Not clear |
| Krista Eschbach, Kelly G Knup. Stiripentol for the treatment of seizures in Dravet syndrome. Expert review of clinical pharmacology. vol 12. issue 5. 2019-05-16. PMID:31017478. |
the approval comes at a time of other treatment options also receiving approval (cannabidiol) and several products in ongoing studies (fenfluramine, tak-935) providing additional treatment options and hope on the horizon for those impacted by this severe epilepsy syndrome. |
2019-05-16 |
2023-08-13 |
Not clear |
| Kerri A Schoedel, Isabella Szeto, Beatrice Setnik, Edward M Sellers, Naama Levy-Cooperman, Catherine Mills, Tilden Etges, Kenneth Sommervill. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial. Epilepsy & behavior : E&B. vol 88. 2019-05-01. PMID:30286443. |
treatment with a highly purified oral solution of cannabidiol (cbd), derived from the plant cannabis sativa l., demonstrated some evidence of central nervous system (cns)-related adverse events in patients enrolled in phase 3 trials for treatment of childhood-onset epilepsy. |
2019-05-01 |
2023-08-13 |
human |
| Kerrie-Anne Chen, Michelle A Farrar, Michael Cardamone, John A Lawso. Cannabis for paediatric epilepsy: challenges and conundrums. The Medical journal of Australia. vol 208. issue 3. 2019-03-27. PMID:29438649. |
cannabis for paediatric epilepsy: challenges and conundrums. |
2019-03-27 |
2023-08-13 |
Not clear |
| Kerrie-Anne Chen, Michelle A Farrar, Michael Cardamone, John A Lawso. Cannabis for paediatric epilepsy: challenges and conundrums. The Medical journal of Australia. vol 208. issue 3. 2019-03-27. PMID:29438649. |
the mechanism of cannabidiol in paediatric epilepsy is unclear but is thought to play a role in modulation of synaptic transmission. |
2019-03-27 |
2023-08-13 |
Not clear |
| Orrin Devinsky, Chloe Verducci, Elizabeth A Thiele, Linda C Laux, Anup D Patel, Francis Filloux, Jerzy P Szaflarski, Angus Wilfong, Gary D Clark, Yong D Park, Laurie E Seltzer, E Martina Bebin, Robert Flamini, Robert T Wechsler, Daniel Friedma. Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes. Epilepsy & behavior : E&B. vol 86. 2019-03-25. PMID:30006259. |
we studied our collective open-label, compassionate use experience in using cannabidiol (cbd) to treat epilepsy in patients with cdkl5 deficiency disorder and aicardi, doose, and dup15q syndromes. |
2019-03-25 |
2023-08-13 |
Not clear |
| Giulia S Porcari, Cary Fu, Emily D Doll, Emma G Carter, Robert P Carso. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center. Epilepsy & behavior : E&B. vol 80. 2019-03-21. PMID:29429908. |
efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: practical experiences in a tertiary medical center. |
2019-03-21 |
2023-08-13 |
Not clear |
| Giulia S Porcari, Cary Fu, Emily D Doll, Emma G Carter, Robert P Carso. Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center. Epilepsy & behavior : E&B. vol 80. 2019-03-21. PMID:29429908. |
cannabidiol (cbd), one of many constituents of the cannabis sativa or marijuana plant, has received renewed interest in the treatment of epilepsy. |
2019-03-21 |
2023-08-13 |
Not clear |
| Barbara Hansen, Magdalena Szaflarski, E Martina Bebin, Jerzy P Szaflarsk. Affiliate stigma and caregiver burden in intractable epilepsy. Epilepsy & behavior : E&B. vol 85. 2019-03-21. PMID:29886019. |
in a highly select group of patients with refractory epilepsy recruited mostly from a cannabidiol (cbd) clinic, this study demonstrated that caregivers experience affiliate stigma, which is significantly associated with higher burden levels. |
2019-03-21 |
2023-08-13 |
Not clear |
| David Neubauer, Mirjana Perković Benedik, Damjan Osredka. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia. Epilepsy & behavior : E&B. vol 81. 2019-03-14. PMID:29526578. |
cannabidiol for treatment of refractory childhood epilepsies: experience from a single tertiary epilepsy center in slovenia. |
2019-03-14 |
2023-08-13 |
Not clear |
| David Neubauer, Mirjana Perković Benedik, Damjan Osredka. Cannabidiol for treatment of refractory childhood epilepsies: Experience from a single tertiary epilepsy center in Slovenia. Epilepsy & behavior : E&B. vol 81. 2019-03-14. PMID:29526578. |
cannabidiol (cbd) has been suggested as a potential treatment for refractory epilepsies. |
2019-03-14 |
2023-08-13 |
Not clear |
| Sean Pric. Oversold? Has Cannabis Oil Been Overhyped in Texas? Texas medicine. vol 114. issue 5. 2019-03-08. PMID:30802289. |
will cannabis oil live up to its hype for epilepsy patients in texas? |
2019-03-08 |
2023-08-13 |
Not clear |
| Jerzy P Szaflarski, Elizabeth Martina Bebin, Anne M Comi, Anup D Patel, Charuta Joshi, Daniel Checketts, Jules C Beal, Linda C Laux, Lisa M De Boer, Matthew H Wong, Merrick Lopez, Orrin Devinsky, Paul D Lyons, Pilar Pichon Zentil, Robert Wechsle. Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results. Epilepsia. vol 59. issue 8. 2019-02-04. PMID:29998598. |
long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: expanded access program results. |
2019-02-04 |
2023-08-13 |
Not clear |
| Jerzy P Szaflarski, Elizabeth Martina Bebin, Anne M Comi, Anup D Patel, Charuta Joshi, Daniel Checketts, Jules C Beal, Linda C Laux, Lisa M De Boer, Matthew H Wong, Merrick Lopez, Orrin Devinsky, Paul D Lyons, Pilar Pichon Zentil, Robert Wechsle. Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results. Epilepsia. vol 59. issue 8. 2019-02-04. PMID:29998598. |
since 2014, cannabidiol (cbd) has been administered to patients with treatment-resistant epilepsies (tres) in an ongoing expanded-access program (eap). |
2019-02-04 |
2023-08-13 |
Not clear |